Lantern Pharma Inc. - Common Stock (NQ:LTRN)

2.160 +0.050 (+2.37%)

Streaming Delayed Price Updated: 12:58 PM EDT, Aug 25, 2026 Add to My Watchlist

Price and Volume

Volume	66,450
Open	2.110
Bid (Size)	2.160 (100)
Ask (Size)	2.290 (200)
Prev. Close	2.110
Today's Range	2.100 - 2.340
52wk Range	1.110 - 4.703
Shares Outstanding	11,184,423
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript ↗

August 21, 2026

LP-300 shows strong efficacy in lung cancer while operating losses shrink 25%.

Via The Motley Fool

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Advances AI-Driven Oncology Pipeline, Establishes Open Medicine AI

August 14, 2026

Via Investor Brand Network

Performance

YTD	-30.5%	-30.5%
1 Month	-22.6%	-22.6%
3 Month	-36.1%	-36.1%
6 Month	-15.6%	-15.6%
1 Year	-52.7%	-52.7%

More News

Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update

August 14, 2026

From Lantern Pharma Inc.

Via Business Wire

New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results

August 08, 2026

From New to The Street

Via ACCESS Newswire

InvestorNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Schedules Second-Quarter 2026 Results Webcast

August 07, 2026

Via Investor Brand Network

Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET

August 07, 2026

From Lantern Pharma Inc.

Via Business Wire

Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine

August 03, 2026

From Lantern Pharma Inc.

Via Business Wire

New to The Street TV Announces Broadcast of Show No. 765 Tonight on Bloomberg Television at 6:30 PM ET Featuring Envoy Medical, Graphene Manufacturing Group, Rhino Bitcoin, and Big Sky Industrial

August 01, 2026

From New to The Street

Via ACCESS Newswire

BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) EMA Clears LP-184 Bladder Cancer Trial in Europe

July 28, 2026

Via Investor Brand Network

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer

July 28, 2026

From Lantern Pharma Inc.

Via Business Wire

New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings

July 25, 2026

From New to The Street

Via ACCESS Newswire

BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) Receives U.S. Patent Allowance for LP-184 Biomarker-Based Cancer Treatment Methods

July 23, 2026

Via Investor Brand Network

Lantern Pharma Receives USPTO Notice of Allowance for Patent Covering Biomarker-Guided Treatment with LP-184 (Zirdafulven) in Multiple Solid Tumor Cancers

July 23, 2026

From Lantern Pharma Inc.

Via Business Wire

New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN)

July 18, 2026

From New to The Street

Via ACCESS Newswire

New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin America and MENA, Featuring Sagtec Global, Virtuix, Lantern Pharma and YY Group

July 11, 2026

From New to The Street

Via ACCESS Newswire

BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) Launches AI-Powered ZetaOmics Computational Biology Platform

July 08, 2026

Via Investor Brand Network

Lantern Pharma Launches ZetaOmics™ — an Autonomous, Intelligent “Computational Biologist” That Brings Expert-Grade Bioinformatics, Biostatistics & Reasoning to Every Cancer

July 08, 2026

From Lantern Pharma Inc.

Via Business Wire

New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group

July 04, 2026

From New to The Street

Via ACCESS Newswire

New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.

June 27, 2026

From New to The Street

Via ACCESS Newswire

New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET

June 06, 2026

Via ACCESS Newswire

BioMedNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Reports Phase 2 HARMONIC Trial Data Supporting LP-300 in EGFR-Mutant Lung Cancer

June 02, 2026

Via Investor Brand Network

Lantern Pharma Reports HARMONIC™ Data Showing LP-300 Progression-Free Survival Benefit Deepens with Treatment Duration in EGFR Exon 21 L858R Lung Cancer

June 02, 2026

From Lantern Pharma Inc.

Via Business Wire

New to The Street Broadcasts Nationwide on Bloomberg Television Featuring "Opportunities To Consider(TM)" Across Artificial Intelligence, Healthcare Innovation, Fintech, Digital Assets, and Commodities

May 30, 2026

Via ACCESS Newswire

New to The Street Broadcasts Episode 753 Today at 6:30 PM EST Across Bloomberg Television U.S., MENA, and Latin America Featuring Leaders in VR Defense Training, AI Streaming, Healthcare Innovation, and Global Workforce Technology

May 23, 2026

Via ACCESS Newswire

Lantern Pharma (LTRN) Q1 2025 Earnings Transcript ↗

May 21, 2026

Via The Motley Fool

Frequently Asked Questions

Is Lantern Pharma Inc. - Common Stock publicly traded?

Yes, Lantern Pharma Inc. - Common Stock is publicly traded.

What exchange does Lantern Pharma Inc. - Common Stock trade on?

Lantern Pharma Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Lantern Pharma Inc. - Common Stock?

The ticker symbol for Lantern Pharma Inc. - Common Stock is LTRN on the Nasdaq Stock Market

What is the current price of Lantern Pharma Inc. - Common Stock?

The current price of Lantern Pharma Inc. - Common Stock is 2.160

When was Lantern Pharma Inc. - Common Stock last traded?

The last trade of Lantern Pharma Inc. - Common Stock was at 08/25/26 12:58 PM ET

What is the market capitalization of Lantern Pharma Inc. - Common Stock?

The market capitalization of Lantern Pharma Inc. - Common Stock is 24.16M

How many shares of Lantern Pharma Inc. - Common Stock are outstanding?

Lantern Pharma Inc. - Common Stock has 24M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.